Abstract:Drug discovery is the process of identifying and evaluating molecules for their ability to safely modulate disease, ultimately aiming to make medicines that enhance patient health and quality of life Citation 1 . Historically, this field was marked by serendipitous discoveries such as Fleming's discovery of penicillin, where breakthroughs occurred by chance. The 1960s and 1970s marked a shift towards a more rational approach, with advancements like X-ray crystallography. These advancements not only provided deep insights into protein structures but also laid the groundwork for computational drug discovery, a process that utilizes computer-based algorithms and simulations to predict and analyze the behaviour of potential drug compounds. This evolution in methodology was highlighted in an article in Fortune magazine on 5 October 1981, which described Merck's implementation of computational methods, sparking significant excitement in the field Citation 2 . Subsequently, the rise of biotechnology and genomics in the late twentieth century further advanced drug discovery into a multidisciplinary endeavour, emphasizing experimental models like assay-based testing for detailed drug interaction insights, translational models to connect research with clinical application, and clinical models essential for conducting human trials to evaluate drug safety and efficacy Citation 3 .

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to use artificial intelligence (AI) technology to improve efficiency, reduce costs and increase the success rate in the drug discovery process. Specifically, the paper explores the application of AI in the following key stages: 1. **Target identification and validation**: Analyze complex biological data sets to identify, prioritize, and evaluate potential therapeutic targets, ensuring that these targets are effective, safe, and druggable. 2. **Hit discovery, filtering, and lead optimization**: Use AI for virtual screening to reduce the false - positive rate in high - throughput screening and optimize the molecular docking process to quickly find potential lead compounds. 3. **Drug property prediction**: Predict the physical and chemical properties, biological activity, and toxicity of drugs to ensure that candidate drugs have good safety before entering clinical trials. 4. **De novo drug design**: Use AI to generate new compounds with specific pharmacological and physical - chemical characteristics, accelerating the new drug design process. 5. **Chemical synthesis**: Optimize the chemical synthesis path through AI to improve the synthesis efficiency and accuracy. 6. **Drug repurposing**: Utilize the existing drug knowledge base and discover new drug uses through AI technology, especially the rapid response ability in dealing with emerging diseases (such as COVID - 19). Although AI shows great potential in drug discovery, the paper also points out the current challenges, including algorithmic bias, ethical issues, and the need for a large amount of computing resources. Finally, the paper summarizes the milestone progress of AI in the drug discovery field and looks forward to the future development direction, emphasizing the need to pay attention to ethical and validation issues while making technological progress.

Insights into artificial intelligence utilisation in drug discovery